Keep your finger on the economic pulse of the RWE, HEOR, and Market Access fields.

The live session will focus on the latest salary and bonus trends for professionals in the field, including a comprehensive overview of the ways industry, job level, location, demographics, and more factor into compensation.

Hear from industry experts as they share their reactions to the report’s findings based on personal experiences and engage in a lively Q&A session, voicing your queries and opinions directly to those at the forefront of the field. The discussion will arm you with the knowledge to make informed career decisions and negotiate your next raise with confidence. This event is an essential for anyone involved in health economics and outcomes research (HEOR), real world evidence (RWE), market access, and related areas who wishes to stay informed about current compensation trends and maximize their career development. Secure your place now and be part of the conversation that shapes the future of salaries in the VEA landscape.

Key Topics Include:

  • Compensation Data: View comprehensive graphs and charts that detail recent salary, bonus, and benefits data, focusing on variations across different job sectors and hierarchical levels.
  • Global Trends: Assess and compare compensation packages across various geographic regions, providing a worldwide perspective on remuneration.
  • Biotech & Pharma Sectors: Delve into these industries, examining why they are the most popular job sectors among survey respondents and what compensation looks like within these areas.
  • Industry Expert Insights: Interpret and implement the detailed conclusions and actionable takeaways provided by the report’s expert analysis.

Presenters

Matt McLoughlin, BSc (Hons)

Senior Vice President
Compliance and Categories
Scientist.com

Matt McLoughlin is the Senior Vice President of Compliance & Categories at Scientist.com. He joined in 2016 to build out the functionality of the platform to support sourcing of regulated services and has supported the top pharma companies transform their category strategies to increase efficiency, reduce costs and increase compliance adherence.

Additional Content From Scientist.com